CNSide available for the state of Texas in August 2025 Initial commercial focus on NCI-Designated Cancer Centers and large private healthcare systems Company will expand testing services and broaden regional availability over the next 12 months HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces th ...

Group 1 - Flow Capital Corp. announced a C$15.0 million senior secured note investment in Common Wealth Pension Services Inc., with an initial advance of C$4.0 million [1] - Common Wealth provides a full-stack platform for group retirement plan administration, aimed at enhancing financial security for members and offering competitive retirement benefits for employers [2][4] - The investment from Flow Capital will facilitate Common Wealth in accelerating product innovation, expanding its customer base, and scaling operations to enhance retirement security accessibility in Canada [3] Group 2 - Common Wealth currently serves over 1,100 employers across Canada, with significant adoption among small and medium-sized businesses (SMBs) and their advisors [4] - The company aims to provide a "retirement plan for life" that extends beyond the workplace, and has received the global Innovation Award for Best Technology from Pensions & Investments [4] - Flow Capital focuses on providing flexible growth capital and alternative debt solutions to high-growth companies, helping them achieve growth without the dilutive impact of equity financing [6]

Company Increases Full-Year 2025 GuidanceMIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the second quarter and six months ended June 30, 2025. Second Quarter 2025 Highlights (compared to second quarter 2024): On a reported basis, revenue increased 5% to $524.2 million. On an organic constant currency basis1, revenue increased 10% and was favorably affected by app ...

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the production of purified psychedelic compounds – has successfully produced a GMP-aligned Ibogaine Total Alkaloid extract. The high-purity extract met all microbial safety standards for food-grade consumption, as verified by an accredited third-party laboratory. In 2024, Psyence BioMed acquired an equity stake in PsyLa ...

SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report second quarter 2025 financial results after the close of U.S. financial markets on Thursday, August 7, 2025. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the financial results and provide a corporate update. The liv ...

SHANGHAI, July 31, 2025 (GLOBE NEWSWIRE) -- At the 2025 World Artificial Intelligence Conference (WAIC), former Google CEO Eric Schmidt engaged in an in-depth fireside chat with former Microsoft Executive Vice President Harry Shum, focusing on the challenges and prospects for global AI governance. A Media Snippet accompanying this announcement is available by clicking on this link. Harry Shum first invited Schmidt to share his perspective on the current state of AI development in China. Schmidt pointed out ...

Core Viewpoint - Orrön Energy AB has entered into an agreement to sell a 76 MW solar project in Germany for a total consideration of MEUR 4.0, with MEUR 2.0 paid at closing and the remaining contingent upon approvals [1][2][3] Group 1: Transaction Details - The solar project is located in northeastern Germany and is being developed as an agrivoltaic project, allowing agricultural activities alongside solar power generation [1] - The contingent consideration of MEUR 2.0 is subject to municipal approval of the zoning plan and EU Commission approval of the German Solar Package 1 legislation [1] Group 2: Strategic Implications - This transaction is part of the company's strategy to monetize early-stage projects from its greenfield portfolio to diversify and enhance revenue streams [2] - The CEO of Orrön Energy expressed that this sale demonstrates the company's ability to unlock value early in the development cycle and is a significant step in delivering on its strategy [3] Group 3: Company Overview - Orrön Energy is an independent, publicly listed renewable energy company within the Lundin Group, focusing on high-quality cash flow-generating assets and greenfield growth opportunities in various regions including the Nordics, UK, Germany, and France [5] - The company has significant financial capacity to fund further growth and acquisitions, supported by a major shareholder and a management team with a proven track record [5]

Core Viewpoint - Quantum BioPharma Ltd. announced that its subsidiary, Unbuzzd Wellness Inc., is launching a Regulation D 506(c) offering to raise up to US$5 million for growth and a potential initial public offering, which will not dilute Quantum BioPharma shareholders [1][2]. Company Overview - Quantum BioPharma is a biopharmaceutical company focused on innovative assets and biotech solutions for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [6]. - The company retains a 20.11% ownership stake in Unbuzzd Wellness Inc. and has an agreement for royalty payments of 7% of sales from Unbuzzd until total payments reach US$250 million, after which the royalty rate drops to 3% [6]. Product Information - Unbuzzd is a beverage designed to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms, developed by a team with expertise in pharmacology and medicine [8][9]. - Clinical trials have shown that Unbuzzd can reduce blood alcohol concentration (BAC) by over 40% faster within 30 minutes compared to control subjects, improve alertness, and lessen hangover symptoms significantly [10][13]. Capital Raising Strategy - Unbuzzd has partnered with MZ Digital and Dealmaker to conduct the capital raise campaign, allowing investments through traditional and cryptocurrency payments [3]. - The offering aims to support direct-to-consumer, distributor, and retail expansion plans for Unbuzzd [5].

WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies, Inc., (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has renewed its operating license for its Oneida, TN location for another year. The license renewal to operate an alcohol and drug residential treatment facility was granted by the State of Tennessee’s Department of Mental Health and Substance Abuse Services after a successful annual inspecti ...

NEWPORT NEWS, Va., July 31, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) today reported results for the second quarter of fiscal 2025. Highlights Second quarter revenues were $3.1 billionSecond quarter net earnings were $152 million or $3.86 diluted earnings per shareNew contract awards of $11.9 billion, resulting in record backlog of $56.9 billionEntered into a strategic partnership with C3 AI to expand our use of digital technologies and apply artificial intelligence to accelerate shipbuilding throughputReaff ...